Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Phage-associated lytic enzymes for treatment of Bacillus anthracis and related conditions

Phage-associated lytic enzymes for treatment of Bacillus anthracis and related conditions

US Patent 8580553 · Granted Nov 12, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of lysin to restore/augment antibacterial activity in the presence of pulmon2024
Identification of lysins and derivatives thereof with bactericidal activity agai2024
Endolysins active against Bacillus bacteria, pharmaceutical compositions, and me2024
Chimeric bacteriophage lysin with activity against Staphylococci bacteria2023
Gram-negative lysin-antimicrobial peptide (AMP) polypeptide constructs, lysins, 2023
Compositions and methods comprising lysin PlyCP025 and derivatives thereof2023
Biofilm prevention, disruption and treatment with bacteriophage lysin2022
Lysin polypeptides active against Gram-negative bacteria2022
Use of lysin to restore/augment antibacterial activity in the presence of pulmon2022
Acinetobacter lysins2021
Acinetobacter lysins2021
Streptococcus bacteriophage lysins for detection and treatment of gram positive 2021